TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Sunshine Lake Pharma
Curated by ChEMBL
Sunshine Lake Pharma
Curated by ChEMBL
Affinity DataIC50: 1.60nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Sunshine Lake Pharma
Curated by ChEMBL
Sunshine Lake Pharma
Curated by ChEMBL
Affinity DataIC50: 2.13E+3nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Sunshine Lake Pharma
Curated by ChEMBL
Sunshine Lake Pharma
Curated by ChEMBL
Affinity DataIC50: 5.60E+3nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Sunshine Lake Pharma
Curated by ChEMBL
Sunshine Lake Pharma
Curated by ChEMBL
Affinity DataIC50: 6.40E+3nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Sunshine Lake Pharma
Curated by ChEMBL
Sunshine Lake Pharma
Curated by ChEMBL
Affinity DataIC50: 7.79E+3nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Sunshine Lake Pharma
Curated by ChEMBL
Sunshine Lake Pharma
Curated by ChEMBL
Affinity DataIC50: 8.65E+3nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Sunshine Lake Pharma
Curated by ChEMBL
Sunshine Lake Pharma
Curated by ChEMBL
Affinity DataIC50: 8.71E+3nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Sunshine Lake Pharma
Curated by ChEMBL
Sunshine Lake Pharma
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Sunshine Lake Pharma
Curated by ChEMBL
Sunshine Lake Pharma
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Sunshine Lake Pharma
Curated by ChEMBL
Sunshine Lake Pharma
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Sunshine Lake Pharma
Curated by ChEMBL
Sunshine Lake Pharma
Curated by ChEMBL
Affinity DataIC50: 1.20E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Sunshine Lake Pharma
Curated by ChEMBL
Sunshine Lake Pharma
Curated by ChEMBL
Affinity DataIC50: 1.45E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Sunshine Lake Pharma
Curated by ChEMBL
Sunshine Lake Pharma
Curated by ChEMBL
Affinity DataIC50: 1.75E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Sunshine Lake Pharma
Curated by ChEMBL
Sunshine Lake Pharma
Curated by ChEMBL
Affinity DataIC50: 1.80E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Sunshine Lake Pharma
Curated by ChEMBL
Sunshine Lake Pharma
Curated by ChEMBL
Affinity DataIC50: 1.86E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Sunshine Lake Pharma
Curated by ChEMBL
Sunshine Lake Pharma
Curated by ChEMBL
Affinity DataIC50: 2.68E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Sunshine Lake Pharma
Curated by ChEMBL
Sunshine Lake Pharma
Curated by ChEMBL
Affinity DataIC50: 3.42E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Sunshine Lake Pharma
Curated by ChEMBL
Sunshine Lake Pharma
Curated by ChEMBL
Affinity DataIC50: 5.76E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Sunshine Lake Pharma
Curated by ChEMBL
Sunshine Lake Pharma
Curated by ChEMBL
Affinity DataIC50: 6.74E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Sunshine Lake Pharma
Curated by ChEMBL
Sunshine Lake Pharma
Curated by ChEMBL
Affinity DataIC50: 7.52E+4nMAssay Description:Inhibition of recombinant human MAO-A expressed in Sf9 cells using p-tyramine as substrate preincubated for 15 mins followed by substrate addition fo...More data for this Ligand-Target Pair